Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)

NCT03554005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: PEG Interferon Alfa-2b
DRUG: Acetaminophen

Sponsor

Merck Sharp & Dohme LLC